Mechanisms of Resistance
ChemicalBook > CAS DataBase List > Streptococcus Pneumoniae

Streptococcus Pneumoniae

Mechanisms of Resistance
Product Name
Streptococcus Pneumoniae
Chemical Name
Streptococcus Pneumoniae
Synonyms
StreptococcusPneumoniae
CBNumber
CB21031681
Formula Weight
0
MOL File
Mol file
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Usbiological
Product number
474328
Product name
Streptococcus Pneumoniae
Packaging
100ul
Price
$586
Updated
2021/12/16
More
Less

Streptococcus Pneumoniae Chemical Properties,Usage,Production

Mechanisms of Resistance

Acquired multidrug resistance in Str. pneumoniae has become a worldwide health problem, with increasing incidence of resistance to β-lactams, macrolides, lincosamides and tetracyclines in most parts of the world in the last three decades. The MIC of penicillin for sensitive strains of pneumococci is <0.01 mg/L; the first penicillin-resistant isolates, reported in 1967 from Papua New Guinea, showed ‘low-level’ resistance with MICs of up to 1 mg/L, but in 1977 pneumococci were isolated in South Africa showing ‘high-level’ resistance with penicillin MICs of >1 mg/L. High-level penicillin resistance has so far been confined to a few serotypes, whereas low-level resistance is now found in nearly all the common serotypes. There is a wide geographical variation in the prevalence of penicillin-resistant pneumococci, even between regions of a particular country.
The resistance of Str. pneumoniae to fluoroquinolones is due to chromosomal mutations in the DNA gyrase (gyrA and gyrB) and topoisomerase IV (parC and parE) and/or active efflux. Both mechanisms have so far been reported at low prevalence (<1%) in a majority of countries but with higher frequency in China (4–14%), Japan (0.5–6%) and Italy (6%). This is a cause for concern, given the usefulness of newer generation fluoroquinolones for the treatment of lower respiratory tract infections.
Respiratory and bloodstream infections with strains of pneumococci showing low- to moderate-level penicillin resistance (MIC <4.0 mg/L) can be treated with high doses of penicillin, amoxicillin or cephalosporins as there is no firm evidence that this level of penicillin resistance is associated with increased risk of treatment failure. 

Streptococcus Pneumoniae Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Streptococcus Pneumoniae Suppliers

Shanghai Kanglang Biotechnology Co., Ltd.
Tel
021-61998208 18217752821
Fax
021-37680378
Email
sales@klbio.cn
Country
China
ProdList
9618
Advantage
58
Shanghai Zeye Biotechnology Co., Ltd.
Tel
021-61998551 13122364865
Email
sale1@shzysw.net
Country
China
ProdList
9772
Advantage
58
Shanghai Sig Biotechnology Co., LTD
Tel
021-57810052 18930344717
Fax
021-57810052
Email
2089316240@qq.com
Country
China
ProdList
9395
Advantage
58
Shanghai Jingfeng Biotechnology Co., Ltd
Tel
17301805756 17301805756
Email
69787182@qq.com
Country
China
ProdList
7989
Advantage
58
Tel
18153089275
Email
3032079623@qq.com
Country
China
ProdList
19438
Advantage
58
United States Biological
Tel
--
Fax
--
Email
sales@advtechind.com
Country
United States
ProdList
6075
Advantage
58